Dyspnoea, lung function and CT findings 3 months after hospital admission for COVID-19.

COVID-19 Dyspnea Hospitals Humans Lung / diagnostic imaging Prospective Studies Quality of Life SARS-CoV-2 Tomography, X-Ray Computed

Journal

The European respiratory journal
ISSN: 1399-3003
Titre abrégé: Eur Respir J
Pays: England
ID NLM: 8803460

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 09 09 2020
accepted: 18 11 2020
pubmed: 12 12 2020
medline: 22 6 2021
entrez: 11 12 2020
Statut: epublish

Résumé

The long-term pulmonary outcomes of coronavirus disease 2019 (COVID-19) are unknown. We aimed to describe self-reported dyspnoea, quality of life, pulmonary function and chest computed tomography (CT) findings 3 months following hospital admission for COVID-19. We hypothesised outcomes to be inferior for patients admitted to intensive care units (ICUs), compared with non-ICU patients.Discharged COVID-19 patients from six Norwegian hospitals were enrolled consecutively in a prospective cohort study. The current report describes the first 103 participants, including 15 ICU patients. The modified Medical Research Council (mMRC) dyspnoea scale, the EuroQol Group's questionnaire, spirometry, diffusing capacity of the lung for carbon monoxide (

Identifiants

DOI: 10.1183/13993003.03448-2020 PMID: 33303540 PMC: PMC7736755
pubmed: 33303540
pii: 13993003.03448-2020
doi: 10.1183/13993003.03448-2020
pmc: PMC7736755
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright ©ERS 2021.

Déclaration de conflit d'intérêts

Conflict of interest: T.V. Lerum has nothing to disclose. Conflict of interest: T.M. Aaløkken has nothing to disclose. Conflict of interest: E. Brønstad has nothing to disclose. Conflict of interest: B. Aarli reports personal fees for lectures and advisory board work from AstraZeneca, personal fees for lectures from GlaxoSmithKline, Novartis, Boehringer Ingelheim and Chiesi Pharma, outside the submitted work. Conflict of interest: E. Ikdahl has nothing to disclose. Conflict of interest: K.M.A. Lund has nothing to disclose. Conflict of interest: M.T. Durheim reports grants and personal fees from Boehringer Ingelheim, personal fees from Roche and AstraZeneca, outside the submitted work. Conflict of interest: J.R. Rodriguez has nothing to disclose. Conflict of interest: C. Meltzer has nothing to disclose. Conflict of interest: K. Tonby has nothing to disclose. Conflict of interest: K. Stavem has nothing to disclose. Conflict of interest: O.H. Skjønsberg has nothing to disclose. Conflict of interest: H. Ashraf reports grants from Boehringer Ingelheim, during the conduct of the study. Conflict of interest: G. Einvik reports grants from Boehringer Ingelheim, during the conduct of the study; personal fees for consultancy from AstraZeneca AB, outside the submitted work.

Références

Respir Care. 2016 May;61(5):689-99
pubmed: 27121623
Lancet Respir Med. 2020 Aug;8(8):807-815
pubmed: 32422178
Clin Infect Dis. 2020 Nov 19;71(16):2199-2206
pubmed: 32407459
Value Health. 2012 Jul-Aug;15(5):708-15
pubmed: 22867780
Int J Infect Dis. 2020 Oct;99:485-488
pubmed: 32841688
Eur Respir J. 2017 Jan 3;49(1):
pubmed: 28049168
Radiology. 2008 Mar;246(3):697-722
pubmed: 18195376
Am J Respir Crit Care Med. 1994 Mar;149(3 Pt 1):630-5
pubmed: 8118630
Respir Res. 2020 Jun 29;21(1):163
pubmed: 32600344
Eur Respir J. 2012 Dec;40(6):1324-43
pubmed: 22743675
Am J Respir Crit Care Med. 2019 Oct 15;200(8):e70-e88
pubmed: 31613151
Radiology. 2020 Oct;297(1):E197-E206
pubmed: 32407255
Eur Respir J. 2014 Dec;44(6):1428-46
pubmed: 25359355
Eur Radiol. 2020 Aug;30(8):4356-4357
pubmed: 32193637
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Br Med J. 1959 Aug 29;2(5147):257-66
pubmed: 13823475
Respir Med. 2015 Jul;109(7):897-903
pubmed: 26028484
EClinicalMedicine. 2020 Aug;25:100463
pubmed: 32838236
Qual Life Res. 2011 Dec;20(10):1727-36
pubmed: 21479777
J Rehabil Med. 2020 May 25;52(5):jrm00063
pubmed: 32449782
Occup Med (Lond). 2017 Aug 1;67(6):496-497
pubmed: 28898975
Lancet Respir Med. 2020 Sep;8(9):839-842
pubmed: 32758440
Eur Respir J. 2017 Sep 11;50(3):
pubmed: 28893868

Auteurs

Tøri Vigeland Lerum (TV)

Dept of Pulmonary Medicine, Oslo University Hospital Ullevål, Oslo, Norway.

Trond Mogens Aaløkken (TM)

Dept of Radiology and Nuclear Medicine, Oslo University Hospital Ullevål, Oslo, Norway.
Institute for Clinical Medicine, University of Oslo, Oslo, Norway.

Eivind Brønstad (E)

Thoracic Dept, St Olavs Hospital, Trondheim, Norway.
Dept of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences NTNU, Trondheim, Norway.

Bernt Aarli (B)

Dept of Thoracic Medicine, Haukeland University Hospital, Haukeland, Norway.
Dept of Clinical Science, University of Bergen, Bergen, Norway.

Eirik Ikdahl (E)

Pulmonary Dept, Akershus University Hospital, Lørenskog, Norway.

Kristine Marie Aarberg Lund (KMA)

Dept of Infectious Diseases, Østfold Hospital Trust Kalnes, Grålum, Norway.

Michael T Durheim (MT)

Institute for Clinical Medicine, University of Oslo, Oslo, Norway.
Dept of Respiratory Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.

Jezabel Rivero Rodriguez (JR)

Dept of Radiology and Nuclear Medicine, Oslo University Hospital Ullevål, Oslo, Norway.

Carin Meltzer (C)

Dept of Radiology and Nuclear Medicine, Oslo University Hospital Ullevål, Oslo, Norway.

Kristian Tonby (K)

Institute for Clinical Medicine, University of Oslo, Oslo, Norway.
Dept of Infectious Diseases, Oslo University Hospital Ullevål, Oslo, Norway.

Knut Stavem (K)

Institute for Clinical Medicine, University of Oslo, Oslo, Norway.
Pulmonary Dept, Akershus University Hospital, Lørenskog, Norway.
Health Services Research Unit, Akershus University Hospital, Lørenskog, Norway.
ORCID: 0000-0003-4512-8000

Ole Henning Skjønsberg (OH)

Dept of Pulmonary Medicine, Oslo University Hospital Ullevål, Oslo, Norway.
Institute for Clinical Medicine, University of Oslo, Oslo, Norway.

Haseem Ashraf (H)

Institute for Clinical Medicine, University of Oslo, Oslo, Norway.
Dept of Diagnostic Imaging, Akershus University Hospital, Lørenskog, Norway.
Shared last authors.

Gunnar Einvik (G)

Institute for Clinical Medicine, University of Oslo, Oslo, Norway.
Pulmonary Dept, Akershus University Hospital, Lørenskog, Norway.
Shared last authors.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › COVID-19 › Dyspnoea, lung function and CT findings 3...
questionsmedicales.fr › États, signes et symptômes pathologiques › Signes et symptômes › Signes et symptômes respiratoires › Dyspnée › Dyspnoea, lung function and CT findings 3...
questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Établissements de santé › Hôpitaux › Dyspnoea, lung function and CT findings 3...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Dyspnoea, lung function and CT findings 3...
questionsmedicales.fr › Appareil respiratoire › Poumon › Dyspnoea, lung function and CT findings 3...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études prospectives › Dyspnoea, lung function and CT findings 3...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Mesures épidémiologiques › Démographie › État de santé › Qualité de vie › Dyspnoea, lung function and CT findings 3...
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Nidovirales › Coronaviridae › Coronavirus › Betacoronavirus › Virus du SRAS › SARS-CoV-2 › Dyspnoea, lung function and CT findings 3...
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Imagerie diagnostique › Tomographie › Tomographie à rayons X › Tomodensitométrie › Dyspnoea, lung function and CT findings 3...